These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2968274)

  • 21. The effects of pyridinium salts, structurally related compounds of 1-methyl-4-phenylpyridinium ion (MPP+), on tyrosine hydroxylation in rat striatal tissue slices.
    Hirata Y; Sugimura H; Takei H; Nagatsu T
    Brain Res; 1986 Nov; 397(2):341-4. PubMed ID: 3099974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice.
    Sundström E; Goldstein M; Jonsson G
    Eur J Pharmacol; 1986 Nov; 131(2-3):289-92. PubMed ID: 3493159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the mechanism of the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Heikkila RE; Nicklas WJ; Duvoisin RC
    Adv Neurol; 1987; 45():149-52. PubMed ID: 3103384
    [No Abstract]   [Full Text] [Related]  

  • 24. Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ion.
    Wagner GC; Carelli RM; Jarvis MF
    Neuropharmacology; 1986 May; 25(5):559-61. PubMed ID: 3488515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure.
    Choi SJ; Panhelainen A; Schmitz Y; Larsen KE; Kanter E; Wu M; Sulzer D; Mosharov EV
    J Biol Chem; 2015 Mar; 290(11):6799-809. PubMed ID: 25596531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpyridinium ion (MPP+) and the structurally related compounds in vitro and in vivo.
    Nagatsu T; Hirata Y
    Eur Neurol; 1987; 26 Suppl 1():11-5. PubMed ID: 2884110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium ion (MPP+) in isolated mitochondria from mouse brains.
    Mizuno Y; Suzuki K; Sone N; Saitoh T
    Neurosci Lett; 1987 Oct; 81(1-2):204-8. PubMed ID: 3501080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The sensitivity of nigrostriatal dopamine neurons to MPP+ does not increase with age.
    Irwin I; Ricaurte GA; DeLanney LE; Langston JW
    Neurosci Lett; 1988 Apr; 87(1-2):51-6. PubMed ID: 3260017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural effects and supersensitivity in the rat following intranigral MPTP and MPP+ administration.
    Lange KW
    Eur J Pharmacol; 1990 Jan; 175(1):57-61. PubMed ID: 2323346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central hypothermic effects of some analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium ion (MPP+).
    Satoh N; Yonezawa A; Tadano T; Kisara K; Arai Y; Kinemuchi H
    Neurosci Lett; 1987 Sep; 80(1):100-5. PubMed ID: 3498916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracerebroventricular administration of 1-methyl-4-phenylpyridinium ion in mice: effects of simultaneously administered nomifensine, deprenyl, and 1-t-butyl-4,4-diphenylpiperidine.
    Mihatsch W; Russ H; Przuntek H
    J Neural Transm; 1988; 71(3):177-88. PubMed ID: 3128644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW; Hemrick-Luecke SK; Perry KW
    J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinal dopamine sensitivity to MPP+ toxicity: electrophysiological and biochemical evaluation.
    Harnois C; Marcotte G; Daigle M; Di Paolo T
    Neurosci Lett; 1989 Dec; 107(1-3):19-25. PubMed ID: 2616030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
    Chan P; Langston JW; Di Monte DA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.
    Rollema H; Skolnik M; D'Engelbronner J; Igarashi K; Usuki E; Castagnoli N
    J Pharmacol Exp Ther; 1994 Jan; 268(1):380-7. PubMed ID: 8301579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-Methyl-4-phenylpyridinium (MPP+) increases oxidation of cytochrome-b in rat striatal slices.
    Sanchez-Ramos JR; Hollinden GE; Sick TJ; Rosenthal M
    Brain Res; 1988 Mar; 443(1-2):183-9. PubMed ID: 3258785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of aromatic L-aminoacid decarboxylase in clonal pheochromocytoma PC12h cells by N-methyl-4-phenylpyridinium ion (MPP+).
    Naoi M; Takahashi T; Ichinose H; Nagatsu T
    Biochem Biophys Res Commun; 1988 Apr; 152(1):15-21. PubMed ID: 3258744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in vitro model of 1-methyl-4-phenyl-pyridinium (MPP+) toxicity: incubation of rabbit caudate nucleus slices with MPP+ followed by biochemical and functional analysis.
    Feuerstein TJ; Hedler L; Jackisch R; Hertting G
    Br J Pharmacol; 1988 Oct; 95(2):449-58. PubMed ID: 3265882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased sensitivity of mice to tremorogenic agents following MPP+.
    Wagner GC; Walsh SL
    Psychopharmacology (Berl); 1987; 92(4):470-2. PubMed ID: 3114800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue culture model for studying MPTP toxicity to dopamine neurons.
    Mytilineou C; Cohen G
    Adv Neurol; 1987; 45():145-8. PubMed ID: 3493622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.